WADA 2026 Annual Report: More Samples Tested, but the Growth Curve Is Flattening

In 2026, WADA collected 288,865 test samples. In 2026, the total was 297,965 — an additional 9,100 samples, or 3.2%. Twelve months earlier, the growth rate had been 12.5%. Within a single reporting cycle, the global expansion of testing slowed by nearly a factor of four. That was the first data point I checked when the World Anti-Doping Agency's 2026 annual report was released, and it raises a far more uncomfortable issue than the "WADA ramps up sample testing" headline most outlets ran.

WADA is not a sports federation. It is the body that coordinates rules, monitors compliance and governs the finances of the entire anti-doping system, reaching from the International Olympic Committee down to hundreds of national anti-doping organisations. Its annual report therefore does not tell the story of athletes; it tells the story of a machine. And that machine, according to the document itself, is moving through a transition marked by a very specific date: 1 January 2027.

That is when the 2027 World Anti-Doping Code — adopted in Busan, South Korea — formally takes effect. For any federation, including World Aquatics, this is not an administrative footnote. It is a deadline for adjusting procedures, training staff and arranging budgets.

But before 2027 arrives, it is worth looking at what is happening right now.

The most stable data point in the entire report is not the sample count, but the adverse analytical finding (AAF) rate, which has sat almost motionless around 0.78% for three consecutive years.

Specifically: 0.77% in 2026, 0.80% in 2026 and 0.78% in 2026. The range is just 0.03 percentage points. Across three years and hundreds of thousands of samples a year, that is stable enough to treat as a genuine baseline signal rather than noise. And it leads to a conclusion neither camp can easily weaponise: sample numbers are rising, but the detection rate is not. If true positivity were escalating, the rate would have to tick up. It has not.

That can mean two things. One is that actual doping prevalence is relatively stable. The other is that the system is testing smarter, targeting better groups, so the detection rate holds even as coverage widens. The report does not allow the two possibilities to be separated, and an honest data analyst has to say so instead of picking a side.

Compliance is where the trouble sits.

In the report, WADA conducted nine compliance audits. Average non-conformities fell from 25.5 to 20. The comfortable reading is that "the system is improving". But one detail is buried fairly deep: testing-related non-conformities make up 45% of all findings, up 11% year on year, and 23% of those are classified as critical.

In other words, the machine is tightening at every stage except the most important one — sample collection. For a system in which every later judgment rests on sampling data, that is a paradox hard to ignore. And for swimming, a sport that depends on out-of-competition testing programmes spread across many events and distances, the consequence shows up not on the results board but in trust.

One more figure belongs beside that: the audit sample is just nine. Nine audits cannot establish a global trend. Such a small sample can tilt toward whichever countries were selected, and the report does not disclose the selection method. The railway behind Risdon led nowhere — that emptiness tells the whole story better than the finish line; here, the gap in audit sampling methodology says more than the 20-versus-25.5 figure.

Then there is the money.

WADA closed the year with a budget shortfall of 8.3 million US dollars against plan, with the United States withholding 3.8 million and Russia owing 3.9 million. Read alongside a net surplus of 1.2 million dollars, the picture turns strange: an organisation reporting a net profit while missing large contributions usually means costs were cut or investment deferred. For an agency whose core output is testing capacity, where the cuts land is fairly predictable.

At the same time, WADA announced a strategic shift away from the traditional athlete-testing model toward investigations and prevention. The figures it cites are impressive: more than 250 investigation operations, 88 laboratories dismantled and over 90 tonnes of substances seized. This is a sensible direction in resource terms, and also one that makes the raw sample count an increasingly weak indicator if it stands alone.

Testing data in the report are presented as a continuous series from 2026 to 2026, not as a single point. That presentation matters: it lets readers see seven years of a system instead of one isolated year. For anyone trying to judge WADA's real capacity, the series is more useful than any press release line. It also shows the growth rate is nowhere near linear, and that the peak of the period is not the most recent year.

One more milestone deserves note: WADA and the Athlete Council ran a consultation with more than 600 athletes and commissions from over 60 countries and more than 70 sports. This is a clear legitimacy-building effort. What the report does not answer is whether that input actually changed the substance of the code or stopped at process.

For swimming, the most direct channel of impact is the out-of-competition testing programmes run jointly by World Aquatics and national organisations. Swimming has a large number of events and distances, which means the number of samples needed to maintain equivalent coverage is also large. When resources tighten, smaller federations are usually the first to lose out-of-competition slots. That is what the global figure cannot capture: 297,965 samples sounds like a lot, but how they are distributed is the real question.

Now to the counterintuitive part.

The report's headline is about ramping up sample collection. The data inside describe a curve that is saturating. Technically the two do not contradict each other — it is still growth — but they send different signals. The Gatlin–Coleman equation taught me that speed is never a single variable; neither is an anti-doping system. When an organisation grows 12.5% and then 3.2%, the right question is not "how much growth" but "what is capping it". The answer most likely lies in the financial lines above.

The second common reading also needs correcting. Many will read a flat AAF rate at 0.78% as evidence that clean sport is stable. That reading ignores the base-rate problem. When testing coverage widens to less-suspected groups, the detection rate is naturally diluted. A flat rate while coverage expands may signal better targeting, or dilution, and the report does not distinguish between them.

The least-discussed point: people usually ask who tests the athletes, rarely who tests the testers. A funding model dependent on voluntary contributions from countries that are themselves subject to testing raises a structural question that no dataset can settle.

The period between now and 1 January 2027 is a compliance gap. The new rules have been adopted but are not yet in force. In that window, old-rule behaviour still has an incentive to persist, especially at under-resourced national anti-doping organisations — the group that dominates the 45% of testing non-conformities. For smaller swimming federations, this is the phase where fairness is most likely to erode within the entire cycle.

Based on my years of following international swimming meets and Olympic cycles, the biggest doping controversies in swimming have almost never started with a positive sample. They start with a gap: a sample not collected, a test skipped, a country without the resources to maintain an out-of-competition schedule. The COVID-era laboratory taught me that data feels pain — if only we listen. The seven data points from 2026 to 2026 in this report do not shout. They simply show a system holding its steering steady while the fuel begins to run low.

Every record is a confirmed hypothesis; every failure is an equation waiting to be solved again. The equation waiting here is not on a lane line but in the balance sheet of the testing machine itself. If the 8.3 million dollar shortfall keeps recurring, testing capacity will not collapse within a single year. It will erode quietly, in the federations with the least voice, at the distances drawing the least attention — and by the time a major case breaks, people will ask why nobody caught it earlier. The 2027 Code takes effect on 1 January 2027; the open question is whether the system will have enough money to enforce it.